Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,092 | Dovepress* | 6,137+ | 1,382 | 7,519 | |
PubMed Central* | 955 | 397 | 1,352 | ||
Totals | 7,092 | 1,779 | 8,871 | ||
*Since 16 March 2016 +Since July 2016 |
View citations on PubMed and Google Scholar